vs
Side-by-side financial comparison of CHEMUNG FINANCIAL CORP (CHMG) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
CHEMUNG FINANCIAL CORP is the larger business by last-quarter revenue ($23.8M vs $18.3M, roughly 1.3× ROCKWELL MEDICAL, INC.). CHEMUNG FINANCIAL CORP runs the higher net margin — 32.5% vs -3.0%, a 35.5% gap on every dollar of revenue. On growth, CHEMUNG FINANCIAL CORP posted the faster year-over-year revenue change (20.3% vs -25.6%). CHEMUNG FINANCIAL CORP produced more free cash flow last quarter ($43.8M vs $2.2M). Over the past eight quarters, CHEMUNG FINANCIAL CORP's revenue compounded faster (0.2% CAGR vs -10.1%).
Chemung Canal Trust Company is a New York State chartered trust company based in Elmira, New York. It was founded as a publicly traded bank in 1833.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
CHMG vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.8M | $18.3M |
| Net Profit | $7.7M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 46.1% | -2.2% |
| Net Margin | 32.5% | -3.0% |
| Revenue YoY | 20.3% | -25.6% |
| Net Profit YoY | 30.9% | 26.7% |
| EPS (diluted) | $1.61 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.8M | $18.3M | ||
| Q3 25 | $28.8M | $15.9M | ||
| Q2 25 | $10.1M | $16.1M | ||
| Q1 25 | $25.7M | $18.9M | ||
| Q4 24 | $25.9M | $24.7M | ||
| Q3 24 | $24.3M | $28.3M | ||
| Q2 24 | $23.4M | $25.8M | ||
| Q1 24 | $23.7M | $22.7M |
| Q4 25 | $7.7M | $-554.0K | ||
| Q3 25 | $7.8M | $-1.8M | ||
| Q2 25 | $-6.5M | $-1.5M | ||
| Q1 25 | $6.0M | $-1.5M | ||
| Q4 24 | $5.9M | $-756.0K | ||
| Q3 24 | $5.7M | $1.7M | ||
| Q2 24 | $5.0M | $343.0K | ||
| Q1 24 | $7.0M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 46.1% | -2.2% | ||
| Q3 25 | 35.0% | -9.9% | ||
| Q2 25 | -87.2% | -8.4% | ||
| Q1 25 | 29.9% | -7.2% | ||
| Q4 24 | 29.0% | -2.1% | ||
| Q3 24 | 29.8% | 6.8% | ||
| Q2 24 | 26.8% | 2.0% | ||
| Q1 24 | 38.3% | -5.8% |
| Q4 25 | 32.5% | -3.0% | ||
| Q3 25 | 27.1% | -11.0% | ||
| Q2 25 | -63.9% | -9.3% | ||
| Q1 25 | 23.4% | -8.0% | ||
| Q4 24 | 29.8% | -3.1% | ||
| Q3 24 | 23.5% | 5.9% | ||
| Q2 24 | 21.3% | 1.3% | ||
| Q1 24 | 29.7% | -7.6% |
| Q4 25 | $1.61 | $-0.01 | ||
| Q3 25 | $1.62 | $-0.05 | ||
| Q2 25 | $-1.35 | $-0.05 | ||
| Q1 25 | $1.26 | $-0.04 | ||
| Q4 24 | $1.24 | $-0.02 | ||
| Q3 24 | $1.19 | $0.04 | ||
| Q2 24 | $1.05 | $0.01 | ||
| Q1 24 | $1.48 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $50.1M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $254.7M | $37.0M |
| Total Assets | $2.7B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.1M | $10.7M | ||
| Q3 25 | $107.6M | $13.6M | ||
| Q2 25 | $320.1M | $12.5M | ||
| Q1 25 | $53.4M | $11.4M | ||
| Q4 24 | $47.0M | $15.7M | ||
| Q3 24 | $80.4M | $12.3M | ||
| Q2 24 | $70.2M | $11.9M | ||
| Q1 24 | $94.9M | $6.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $254.7M | $37.0M | ||
| Q3 25 | $245.3M | $37.0M | ||
| Q2 25 | $235.0M | $30.4M | ||
| Q1 25 | $228.3M | $31.5M | ||
| Q4 24 | $215.3M | $32.6M | ||
| Q3 24 | $220.7M | $29.1M | ||
| Q2 24 | $201.2M | $23.5M | ||
| Q1 24 | $197.1M | $20.6M |
| Q4 25 | $2.7B | $57.1M | ||
| Q3 25 | $2.7B | $57.5M | ||
| Q2 25 | $2.9B | $52.6M | ||
| Q1 25 | $2.8B | $54.0M | ||
| Q4 24 | $2.8B | $59.2M | ||
| Q3 24 | $2.8B | $57.1M | ||
| Q2 24 | $2.8B | $53.0M | ||
| Q1 24 | $2.8B | $50.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.42× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.5M | $2.3M |
| Free Cash FlowOCF − Capex | $43.8M | $2.2M |
| FCF MarginFCF / Revenue | 183.7% | 12.0% |
| Capex IntensityCapex / Revenue | 7.1% | 0.5% |
| Cash ConversionOCF / Net Profit | 5.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $71.9M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.5M | $2.3M | ||
| Q3 25 | $12.2M | $-1.3M | ||
| Q2 25 | $9.7M | $1.8M | ||
| Q1 25 | $7.2M | $-3.5M | ||
| Q4 24 | $29.8M | $865.0K | ||
| Q3 24 | $9.2M | $4.3M | ||
| Q2 24 | $6.5M | $1.4M | ||
| Q1 24 | $7.9M | $-2.4M |
| Q4 25 | $43.8M | $2.2M | ||
| Q3 25 | $11.8M | $-1.5M | ||
| Q2 25 | $9.4M | $1.7M | ||
| Q1 25 | $6.9M | $-3.5M | ||
| Q4 24 | $26.2M | $470.0K | ||
| Q3 24 | $8.6M | $4.1M | ||
| Q2 24 | $5.5M | $1.2M | ||
| Q1 24 | $7.9M | $-2.5M |
| Q4 25 | 183.7% | 12.0% | ||
| Q3 25 | 41.1% | -9.6% | ||
| Q2 25 | 92.9% | 10.5% | ||
| Q1 25 | 26.7% | -18.8% | ||
| Q4 24 | 101.2% | 1.9% | ||
| Q3 24 | 35.2% | 14.4% | ||
| Q2 24 | 23.4% | 4.5% | ||
| Q1 24 | 33.1% | -11.1% |
| Q4 25 | 7.1% | 0.5% | ||
| Q3 25 | 1.4% | 1.4% | ||
| Q2 25 | 3.6% | 1.0% | ||
| Q1 25 | 1.3% | 0.3% | ||
| Q4 24 | 14.0% | 1.6% | ||
| Q3 24 | 2.5% | 0.7% | ||
| Q2 24 | 4.4% | 1.1% | ||
| Q1 24 | 0.3% | 0.6% |
| Q4 25 | 5.88× | — | ||
| Q3 25 | 1.57× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.19× | — | ||
| Q4 24 | 5.04× | — | ||
| Q3 24 | 1.60× | 2.57× | ||
| Q2 24 | 1.30× | 4.20× | ||
| Q1 24 | 1.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHMG
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
